Participants were broken into two cohorts. The first cohort received one of three doses of PCRX-201. The second cohort received concurrent pretreatment with an intraarticular corticosteroid ...

Investor’s Corner shines a light on innovative technologies and solutions with high market potential With over two-thirds of ...

Numerous private clinics claim to offer miraculous cures for hard-to-treat medical conditions, even though their treatments ...